logging in or signing up preformulation studies lokhande1 Download Post to : URL : Related Presentations : Let's Connect Share Add to Flag Embed Email Send to Blogs and Networks Add to Channel Copy embed code: Embed: Flash iPad Dynamic Copy Does not support media & animations Automatically changes to Flash or non-Flash embed WordPress Embed Customize Embed URL: Copy Thumbnail: Copy The presentation is successfully added In Your Favorites. Views: 1844 Category: Science & Tech.. License: All Rights Reserved Like it (0) Dislike it (0) Added: March 18, 2012 This Presentation is Public Favorites: 0 Presentation Description No description available. Comments Posting comment... Premium member Presentation Transcript PowerPoint Presentation: Preformulation SEMINAR ON Presented by: Mr. Shailesh. Lokhande Guided By: Mr. Amer Quazi (Head of Pharmaceutics department) 3/18/2012 1PowerPoint Presentation: CONTENTS INTRODUCTION OBJECTIVES PRELIMINARY STUDIES BULK CHARACTERIZATIONS ANALYTICAL MEASURES CONCLUSION REFERENCES 3/18/2012 2PowerPoint Presentation: INTRODUCTION Preformulation testing is the first step in the rational development of dosage forms. It can be defined as “an investigation of physical and chemical property of a drug substance alone and when combined with excipients.” Physiochemical properties are those that can be determined from in vitro experiments. 3/18/2012 3OBJECTIVES : OBJECTIVES The main objective is to generate information useful to the formulation in developing most stable and bioavailable dosage form that mass can be produced. 3/18/2012 4PowerPoint Presentation: Why is Preformulation Important It describes the process of optimizing the delivery of drug thorough determination of physical, chemical properties of new drug molecule that affect drug performance and development of an efficacious stable and safe dosage form. Preformulation studies on a new drug molecule provide useful information for subsequent formulation of a physicochemically stable and biopharmaceutically suitable dosage form. 5 3/18/2012PowerPoint Presentation: 3/18/2012 6 PRELIMINARY EVALLUATION: PRELIMINARY EVALLUATION Once pharmacologically active compound has been identified different project team have responsibility for assuring that compound enters in development process in it`s optimum molecular form. If deficiency is detected then project team decide on molecular modification . e.g.salts , prodrug,,solvets ,polymorphs, Mostly salt & prodrug approches are common . Most salts of organic compound are formed by addition or removal of proton to form ionized drug molecule which is then neutralizad with counter ion. e. g.ephedrine hydrochloride . 3/18/2012 7PowerPoint Presentation: Organic salts are more water soluble than un –ionized molecule. Prodrug are synthetic derivative of drug molecule Pharmaceutical improvement from prodrug include stabilization ,increase or decrease of solubility , crystallinity , taste ,odour . e. g.Erythromycin esolate Once the optimum molecular form of drug has been selected formulation development begin there task in drug development process. 3/18/2012 8PowerPoint Presentation: BULK CHARACTERIZATION 3/18/2012 9 BULK CHARACTERIZATION SOLUBILITY ANALYSIS CRYSTALLINITY &POLYMORPHISM HYGROSCOPICITY FINE PARCTICLE CHARACTERIZATION BULK DENSITY POWDER FLOW PROPERTIES IONIZATION CONSTANT –Pka PH SOLUBILITY PROFILE COMMON ION EFFECT –Ksp THERMAL EFFECTS SOLUBILIZATION PARTITION COEFFICIENT DISSOLUTION STABILITY ANALYSIS STABILITY IN TOXICOLOGY FORMULATION SOLUTION STABILITY PH RATE PROFILE SOLID STATE STABILITY BULK STABILITY COMPATIBILITY1.BULK CHARACTERIZATION: 1. Bulk properties of the solid form such as crystallinity, polymorphism, particle size, powder flow property, and surface characteristics are likely to change during process development. A Crystallinity The crystal habit describes the outer appearance of crystals ( platy, equant, needle, bladed, etc.) and internal structure is arrangement within solid. Compounds have several different habits, depending on the environment for growing crystals. 3/18/2012 10 1.BULK CHARACTERIZATIONPowerPoint Presentation: Changes with internal structure alter crystal habit while chemical changes produces both change in internal structure & crystal habit . Characterization of solid form involves – Verifying that the solid is expected chemical compound. Characterizing internal structure Describing habit of crystal. The internal structure of compound can be classified in following way. 3/18/2012 11PowerPoint Presentation: 12 Chemical compound habits Internal structure crystalline amorphous Single entity Molecular adduct polymorphs Nonstoichiometric inclusion compound Stoichiometric solvates (hydrates) channel layer Cage (clathrate) 3/18/2012PowerPoint Presentation: A crystalline compound may contain either a stoichiometric or nonstoichiometric amount of crystallization solvent. Nonstoichiometric aducts are called as inclusions or clathrates . Stoichiometric aducts are called as solvets molecules. e.g Chloramphenicol palmitate A,B,C & amorphous form are used in suspension then after investigation it was found that form B have increased peak serum level due to more soluble form. 3/18/2012 13PowerPoint Presentation: Analytical method used for characterization Microscopy Differential scanning calorimetry Infrared spectroscopy Thermogravimetric analysis X-ray diffraction 3/18/2012 14PowerPoint Presentation: MICROSCOPY: In this technique substances are examined under the microscope. It gives information about shape, thickness, particle size, etc. of drug molecules. By this method we can study crystal morphology, difference between polymorphic character of molecule. 3/18/2012 15PowerPoint Presentation: Ketoprofen 3/18/2012 16 Differential Scanning Colorimetry : Differential Scanning Colorimetry In DSC, the sample & the reference material are subjected to linear heating , but the temperature of two materials should be same, and a graph is plotted. E.g . Doxorubicin. In both Differential Scanning Colorimetry & Differential Thermal Analysis the heat loss and gain resulting from physical or chemical transitions occurring in a sample. Enthalpic changes both endothermic & exothermic are caused by phase transitions. For example, fusion, sublimation, solid-solid transition & water loss generally produce endothermic effects while crystallization produces exothermic effects 3/18/2012 17PowerPoint Presentation: Differential Scanning Colorimetry 3/18/2012 18 Infrared spectroscopy : Infrared spectroscopy The study of the interaction of electromagnetic radiation with vibrational and rotational resonances within a molecular structure is termed as IR Spectroscopy. IR has the ability to differentiate isomers groups such as Cis -trans double bond compound. Gives an information regarding functional group present in new drug molecule. FT-IR use for both qualitative and quqntitative analysis of sample. 3/18/2012 19 Thermal Gravimetric Analysis: Thermal Gravimetric Analysis It is an excellent analytical procedure for determination of the content of moisture. TGA helps to determine the temperature at which the material losses weight due to evaporation or decomposition. E.g . Cefamandole Naftate . Weight loss begins at 63°C & loss continues at 137°C & at 163°C resulting decomposition. Determine the temperature at which no loss of weight takes place; this indicates the stability of the compound 3/18/2012 20PowerPoint Presentation: . X-RAY DIFFRACTION When a beam of non homogenous x-rays is allowed to pass through a sample the x-ray beam is diffracted & it is recorded by means of photographic plates . Single Crystal X-ray provides the most complete information about the solid state. It is used to differentiate the amophous and crystalline forms. This method is tedious, time consuming & hence unsuitable for routine use. 3/18/2012 21PowerPoint Presentation: B. Polymorphism polymorphism is the ability of the compound to crystallize as more than one distinct crystalline species with different internal structure. Formation of different polymorphs depends on solvents, temperature, pressure, rate of cooling, etc. Polymorphic transitions can also occur during milling, granulating, drying and compressing operations Different polymorphs vary in physical properties such as dissolution, solid-state stability, compatibility , etc 3/18/2012 22C.HYGROSCOCITY : C. HYGROSCOCITY The tendency of a solid to take up water from the atmosphere, as it is subjected to a controlled RH program under isothermal condition i.e. hygroscopicity . Deliquescent materials adsorbs sufficient water to dissolve completely . Changes in moisture level can greatly influence many parameters e.g. chemical stsbility , flowability,comactibility . 3/18/2012 23PowerPoint Presentation: Analytical method used for characterization. Sample of bulk drug are placed in open containers with a thin powder bed to assure maximum atmospheric exposure. These samples are then exposed to range of controlled relative humidity environment prepared with saturated aqueous salts solution. Other method used are TGA ,Karl fischer titration & gas chromatography. 3/18/2012 24 D. fine particle characterization: D. fine particle characterization Study of particle size give an information about solubility, dissolution rate, absorption, etc. particle size and surface area of a solid drug are inversely related to each other. eg : Griseofulvin 3/18/2012 25PowerPoint Presentation: Analytical method used for characterization. Light microscope with calibrated grid Stream counting devices e.g.coulter counter,HIAC counter Sieve analysis & Image analysis BET nitrogen adsorption Scanning electron microscopy 3/18/2012 26 E. Powder flow property: E. Powder flow property The flow properties of a powder will determine the nature and quantity of excipients needed to prepare a compressed or a powder dosage form. This refers mainly to factors such as the ability to process the powder through machines. Powder are classfied as free flowing & non free flowing This subject comes paramount when attempting to develop a solid dosage form containing large percentage of cohesive material. 3/18/2012 27PowerPoint Presentation: Analytical method used for characterization. Free flowing powders may be characterized by simple flow rate apparatus consisting of grounded metal tube from which drug flows through an orifice onto an electronic balance which is connected to strip chart recorder. Another method used is compressibility. Cohesive powders are characterized by tensile testing or evaluated in shear cell. 3/18/2012 282.SOLUBILITY ANALYSIS : 2. SOLUBILITY ANALYSIS A. Drug pKa / Ionization constant pKa is the dissociation constant of a drug. The unionized substances is lipid soluble thus dissolve in lipid material of the membrane and transported by passive diffusion. Where as, the ionized substances is a lipid insoluble therefore permeation is slow. 3/18/2012 29PowerPoint Presentation: The percentage of ionization can be calculated as … For Acidic compounds: For Basic compounds: Degree of ionization depends up on the pH. for acidic drugs pKa ranges from 3-7.5. for basic drugs pKa ranges from 7-11. PH = pKa + log un-ionized drug/ionized drug PH= pKa+log ionized drug/un-ionized drug 3/18/2012 30PowerPoint Presentation: Analytical method used are UV and Visible Spectrophotometry Potentiometric titrations 3/18/2012 31PowerPoint Presentation: UV and Visible Spectrophotometry When organic molecules in solution, or as liquid, are exposed to light in the visible and ultraviolet light regions of spectrum, they absorb light of particular wavelengths depending on the type of electronic transition that is associated with the absorption. The electronic transitions depends on the electron bonding with in the molecule. Spectrophotometry can be used to study to enzyme reaction and to evalute the effect of drug on enzyme. UV study of compounds gives information regarding unsaturation of compounds. 3/18/2012 32PowerPoint Presentation: 3/18/2012 33 B .pH-solubility profile & Common Ion Effect Compounds with acidic/basic functionalities show pH dependent solubility profile. pH= pKa+ log [Cs]/ [Ca] pKa—negative log of the ionization const. [Cs]—molar conc. of salt form in water [Ca]—molar conc. of free acid in water. Total solubility can be given as St= [Ca]+[Cs]. 33PowerPoint Presentation: Solubility Analysis Aqueous Solubility: it is the sum of the individual solubilities for the neutral compound and all ionized species present. For compounds with ionizable groups, aqueous solubility is a function of pH. Intrinsic solubility : It is defined as the number of moles per liter of solute that dissolves into solution. Equilibrium between solute and solution is maintained at a specific temperature, usually 25°C. Units can be expressed as mol/l, mg/ml . 3/18/2012 34PowerPoint Presentation: C. PARTITION COEFFICIENT Partition coefficient influence permeation of a drug across biological membrane. Partition coefficient is a ratio of equilibrium concentration of drug in oil phase to equilibrium concentration of drug in aqueous phase . where, C o -organic phase concentration C w -aqueous phase concentration K=C o /C w 3/18/2012 35 D. DISSOLUTION : D . DISSOLUTION To know the gastrointestinal absorption & other physicochemical properties. The intrinsic dissolution rate is determined by the rotating disc method. The dissolution rate is described by Noyes- Whiteny equation. Analytical method used are Chromatography UV and Visible Spectrophotometry 3/18/2012 36PowerPoint Presentation: CHROMATOGRAPHY In the preform ulation studies, chromatographic techniques such as TLC, HPLC,GC carrying a major role. The major advantages are direct analysis of aqueous samples, high sensitivity, and specific determination of drug concentration, separation of drug from impurities or degradation products. Analytical data from TLC may be required to precisely determine the kinetics of decomposition. HPLC and GC are useful for solubility measurements. 3/18/2012 373.STABILITY ANALYSIS: 3.STABILITY ANALYSIS In this study includes both solutions and solid-state experiments under various conditions for handling, formulation, storage, and in vivo administration. solution phase stability: The effect of pH on stability is important in the development of both oral and Parenteral dosage forms Acid sensitive drugs protected from highly acidic environment of the stomach by coating it with suitable polymers. Solid phase stability depends on several factors like temperature, pH, humidity, hydrolysis, oxidation, etc … 3/18/2012 38STABILITY STUDY : STABILITY STUDY The purpose of stability testing to asses the effect of temp., humidity, light & environmental factor on quality of product Above data used for prediction of shelf life Potency should not loss under recommended storage condition Prediction of storage condition 3/18/2012 39DRUG DEGRADATION MECHANISM: DRUG DEGRADATION MECHANISM Hydrolysis Solvolysis Oxidation Photolysis Metal chelating 3/18/2012 40STABILITY TYPE: STABILITY TYPE TWO TYPE:- 1. Solid state stability Tablet & capsule Free moisture ( 2% req. for compression) 2. Liquid state stability Selection of granulation solvent Study when exposed to G.I.fluid (erythromycin ) 3/18/2012 41Factor affecting solid dosage form stability : Factor affecting solid dosage form stability Moisture Excipient:- starch & povidone more water content Suppository base cause degradation of aspirin Temperature ( polymorphism) Light & oxygen 3/18/2012 42Factor affecting liquid dosage form stability : Factor affecting liquid dosage form stability P H :- catalytic effect of H +, & OH - ions . Hydrolysis in solution Temperature:- arrhenius equ . Solvent effect:- 3/18/2012 43PowerPoint Presentation: CONCLUSION Preformulation studies on a new drug molecule provide useful information for subsequent formulation of a Physicochemically stable and Biopharmaceutically suitable dosage form. Thorough Preformulation work is the foundation of developing efficacious and economical formulations. 3/18/2012 44PowerPoint Presentation: REFERENCES Alfred Martin., Physical pharmacy. 4 th ed. New York: Lippincott Williams & Wilkins; 2001. p. 77-100 Remington, The Science and Practice of Pharmacy, 20th Edition, B.I Publication Pvt Ltd.p.940-42 Leon Lachman, Herbert AL, Joseph LK., The theory and practice of industrial pharmacy, 3 rd ed. Bombay: Varghese publishing house; 1990. p. 171- 196 3/18/2012 45PowerPoint Presentation: …….???? 3/18/2012 46PowerPoint Presentation: 3/18/2012 47 You do not have the permission to view this presentation. In order to view it, please contact the author of the presentation.